AstraZeneca Considers Shifting Primary Listing
Photo: Fredrik Sandberg/TT

AstraZeneca Considers Shifting Primary Listing to US Stock Exchange

Advertisement

Pharmaceutical giant Astra Zeneca is considering moving its primary listing of the share from the London to the New York stock exchange, reports the British The Times. According to the newspaper, the CEO Pascal Soriot is frustrated with the British regulations, including restrictions regarding new medicines as well as pricing of medicines.

Astra Zeneca is listed on the London stock exchange as well as on its equivalent in Stockholm. Today's information made the share at closing have risen by just over 2 percent.

In this story
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All